Stockreport

U.S. IPO Weekly Recap: Keros Therapeutics Rises 35% As Biotechs Beat The IPO Shutdown [Seeking Alpha]

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF SummaryKeros Therapeutics finished the week up 35%, affirming that the biotech industry won't be deterred by current market volatility.The IPO Index jumped 11.3% this pa [Read more]